Журнал "Здоров`я дитини" Том 19, №2, 2024
Повернутися до номеру
Синдром подразненого кишечника в дитячому віці: лікування відповідно до міжнародних рекомендацій
Автори: Бєлоусова О.Ю.
Харківський національний медичний університет МОЗ України, м. Харків, Україна
Рубрики: Педіатрія/Неонатологія
Розділи: Довідник фахівця
Версія для друку
Синдром подразненого кишечника (СПК) визначається відповідно до Римських критеріїв IV функціональних шлунково-кишкових розладів. Вважається, що 10–15 % дітей старшого віку і підлітків страждають від СПК. СПК викликає дискомфорт і біль у животі й може погіршити якість життя дітей. У статті проаналізовано зміни уявлень про патогенетичні механізми, підходи до діагностики й лікування СПК у дітей. Після встановлення діагнозу важливо пояснити батькам і дітям, що серйозного основного захворювання немає, це заспокоєння може бути ефективним лікуванням у значній кількості випадків. Зміна способу життя, управління стресом, дієтичне втручання й пробіотики можуть бути корисними в деяких випадках. Хоча існують лише обмежені докази ефективності фармакологічної терапії, такої як спазмолітики, проносні й протидіарейні засоби, вони відіграють позитивну роль у тяжких випадках.
Irritable bowel syndrome (IBS) is diagnosed according to the Rome IV criteria for functional gastrointestinal disorders. It is estimated that 10–15 % of older children and adolescents suffer from IBS. IBS causes abdominal discomfort and pain and can worsen quality of life in children. The article provides an analysis of changes in ideas about pathogenetic mechanisms, approaches to the diagnosis and treatment of IBS in children. Once the diagnosis of IBS is made, it is important to explain to the parents and children that there is no serious underlying disease. This reassurance may be effective treatment in many cases. Lifestyle modifications, stress management, dietary interventions and probiotics may be beneficial in some cases. Although there is limited evidence for efficacy of pharmacological therapies such as antispasmodics, laxatives, and antidiarrheals, they play a positive role in severe cases.
діти; синдром подразненого кишечника; на основі доказів; абдомінальний больовий синдром; функціональна діарея; функціональний запор; лікування
children; irritable bowel syndrome; evidence-based; abdominal pain syndrome; functional diarrhea; functional constipation; treatment
- Abdel-Hamid SM et al. Formulation of an antispasmodic drug as a topical local anestetic. Int J of Pharmaceutics. 2006;326:107-118.
- Annaházi A, Róka R, Rosztóczy A, Wittmann T. Role of antispasmodics in the treatment of irritable bowel syndrome. World J Gastroente–rol. 2014 May 28;20(20):6031-43. doi: 10.3748/wjg.v20.i20.6031. PMID: 24876726; PMCID: PMC4033443.
- Axelrod CH, Saps M. The Role of Fiber in the Treatment of Functional Gastrointestinal Disorders in Children. Nutrients. 2018 Nov 3;10(11):1650. doi: 10.3390/nu10111650. PMID: 30400292; PMCID: PMC6267171.
- Barbaro MR, Cremon C, Wrona D, Fuschi D, Marasco G, Stanghellini V, Barbara G. Non-Celiac Gluten Sensitivity in the Context of Functional Gastrointestinal Disorders. Nutrients. 2020 Dec 4;12(12):3735. doi: 10.3390/nu12123735. PMID: 33291590; PMCID: PMC7761787.
- Bellini M, Tonarelli S, Nagy AG, Pancetti A, Costa F, Ricchiuti A et al. Low FODMAP Diet: Evidence, Doubts, and Hopes. Nutrients. 2020 Jan 4;12(1):148. doi: 10.3390/nu12010148. PMID: 31947991; PMCID: PMC7019579.
- Biesiekierski JR, Newnham ED, Irving PM, Barrett JS, Haines M, Doecke JD et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol. 2011 Mar;106(3):508-14; quiz 515. doi: 10.1038/ajg.2010.487. Epub 2011 Jan 11. PMID: 21224837.
- Boradyn KM, Przybyłowicz KE, Jarocka-Cyrta E. Low –FODMAP Diet Is Not Effective in Children with Functional Abdominal Pain: A Randomized Controlled Trial. Ann Nutr Metab. 2020;76(5):334-344. doi: 10.1159/000510795. Epub 2020 Oct 19. PMID: 33075788.
- Brusaferro A, Farinelli E, Zenzeri L, Cozzali R, Esposito S. The Management of Paediatric Functional Abdominal Pain Disorders: La–test Evidence. Paediatr Drugs. 2018 Jun;20(3):235-247. doi: 10.1007/s40272-018-0287-z. PMID: 29497992; PMCID: PMC5954057.
- Cooper TE, Fisher E, Gray AL, Krane E, Sethna N, van Tilburg MA, Zernikow B, Wiffen PJ. Opioids for chronic non-cancer pain in children and adolescents. Cochrane Database Syst Rev. 2017 Jul 26;7(7):CD012538. doi: 10.1002/14651858.CD012538.pub2. PMID: 28745394; PMCID: PMC6477875
- de Bruijn CMA, Rexwinkel R, Gordon M, Benninga M, Tabbers MM. Antidepressants for functional abdominal pain disorders in children and adolescents. Cochrane Database Syst Rev. 2021 Feb 9;2(2):CD008013. doi: 10.1002/14651858.CD008013.pub3. PMID: 33560523; PMCID: PMC8094232.
- Devanarayana NM, Rajindrajith S. Irritable bowel syndrome in children: current knowledge, challenges and opportunities. World J Gastroenterol. 2018 Jun 7;24(21):2211-35.
- Drossman D.A. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV. Gastroenterology. 2016;150(6):1262-1279.
- European Medicines Agency. Restrictions on the use of domperidone-containing medicines. 2014. https://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Domperidone_31/European_Commission_final_decision/WC500172573.pdf. Accessed 14 Aug 2021.
- Tabbers MM, DiLorenzo С, Berger MY, Faure C., Langendam MW, Nurko S et al. Evaluation and Treatment of Functional Constipation in Infants and Children: Evidence-Based Recommendations from ESPGHAN and NASPGHAN. JPGN. 2014;58(2):265-281. DOI: 10.1097/MPG.0000000000000266.
- Federal Drug Administration (FDA). Suicidality in children and adolescents being treated with antidepressant medications.2018. https://www.fda.gov/drugs/postmarket-drug-safety-information-patientsand-providers/suicidality-children-and-adolescentsbeing-treated-antidepressant-medications.
- Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut. 2004 Oct;53(10):1459-64.
- Halkjær SI, Christensen AH, Lo BZS, Browne PD, Günther S, Hansen LH, Petersen AM. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study. Gut. 2018 Dec;67(12):2107-2115. doi: 10.1136/gutjnl-2018-316434. Epub 2018 Jul 6. PMID: 29980607.
- Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014 Jan;146(1):67-75.e5. doi: 10.1053/j.gastro.2013.09.046. Epub 2013 Sep 25. PMID: 24076059.
- Hojsak I, Benninga MA, Hauser B et al. Benefits of dietary fibre for children in health and disease. Arch Dis Child. 2022 Mar 11.
- Hollier JM, Czyzewski DI, Self MM, Weidler EM, Smith EO, Shulman RJ. Pediatric irritable bowel syndrome patient and parental characteristics differ by care management type. J Pediatr Gastroenterol Nutr. 2017 Mar;64(3):391-5.
- Huang RC, Palmer LJ, Forbes DA. Prevalence and pattern of childhood abdominal pain in an Australian general practice. J Paediatr Child Health. 2000 Aug;36(4):349-53. doi: 10.1046/j.1440-1754.2000.00513.x. PMID: 10940169.
- Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Functional disorders: children and adolescents. Gastroentero–logy. 2016 May 1;150(6):1456-68.
- Johnsen PH, Hilpüsch F, Cavanagh JP, Leikanger IS, Kolstad C, Valle PC, Goll R. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol Hepatol. 2018 Jan;3(1):17-24. doi: 10.1016/S2468-1253(17)30338-2. Epub 2017 Nov 1. PMID: 29100842.
- Korczak R, Kamil A, Fleige L, Donovan SM, Slavin JL. Dietary fiber and digestive health in children. Nutr Rev. 2017 Apr 1;75(4):241-259. doi: 10.1093/nutrit/nuw068. PMID: 28586481.
- Krasaelap A, Sood MR, Li BUK et al. Efficacy of auricular neurostimulation in adolescents with irritable bowel syndrome in a randomized, double-blind trial. Clin Gastroenterol Hepatol. 2020 Aug;18(9):1987-94.e2.
- Kridler J, Kamat D. Irritable bowel syndrome: a review for general pediatricians. Pediatr Ann. 2016 Jan;45(1):e30-3.
- Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021 Jan 1;116(1):17-44. doi: 10.14309/ajg.0000000000001036. PMID: 33315591.
- Nagarajan N, Morden A, Bischof D, King EA, Kosztowski M, Wick EC, Stein EM. The role of fiber supplementation in the treatment of irritable bowel syndrome: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1002-10. doi: 10.1097/MEG.0000000000000425. PMID: 26148247.
- National Collaborating Centre for Nursing and Supportive Care. Irritable bowel syndrome in adults: Diagnosis and management of irritable bowel syndrome in primary care. Clinical practice guideline, update on March, 2017.
- Paulo AZ, Amancio OM, de Morais MB, Tabacow KM. Low-dietary fiber intake as a risk factor for recurrent abdominal pain in children. Eur J Clin Nutr. 2006 Jul;60(7):823-7. doi: 10.1038/sj.ejcn.1602386. Epub 2006 Feb 1. PMID: 16452916.
- Pourmoghaddas Z, Saneian H, Roohafza H, Gholamre–zaei A. Mebeverine for pediatric functional abdominal pain: a rando–mized, placebo-controlled trial. Biomed Res Int. 2014;2014:191026. doi: 10.1155/2014/191026. Epub 2014 Jun 25. PMID: 25089264; PMCID: PMC4095832.
- Rajindrajith S, Devanarayana NM. Subtypes and symptomatology of irritable bowel syndrome in children and adolescents: a school-based survey using Rome III Criteria. J Neurogastroenterol Motil. 2012;18:298-304.
- Rexwinkel R, Vlieger AM, Saps M, Tabbers MM, Benninga MA. A therapeutic guide on pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specified. Eur J Pediatr. 2022 Jul;181(7):2603-2617. doi: 10.1007/s00431-022-04459-y. Epub 2022 Apr 23. PMID: 35460383; PMCID: PMC9192445.
- Santucci NR, King C, El-Chammas KI et al. Effect of percutaneous electrical nerve field stimulation on mechanosensitivity, sleep, and psychological comorbidities in adolescents with functional abdominal pain disorders. Neurogastroenterol Motil. 2022 Mar 16. e14358.
- Saps M, Youssef N, Miranda A et al. Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology. 2009 Oct;137(4):1261-9.
- Saulnier DM, Riehle K, Mistretta TA, Diaz MA, Mandal D, Raza S et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology. 2011 Nov;141(5):1782-91. doi: 10.1053/j.gastro.2011.06.072. Epub 2011 Jul 8. PMID: 21741921; PMCID: PMC3417828.
- Schechter NL, Coakley R, Nurko S. The Golden Half Hour in Chro–nic Pediatric Pain-Feedback as the First Intervention. JAMA Pediatr. 2021 Jan 1;175(1):7-8. doi: 10.1001/jamapediatrics.2020.1798. PMID: 32628256.
- Shepherd SJ, Lomer MC, Gibson PR. Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol. 2013 May;108(5):707-17. doi: 10.1038/ajg.2013.96. Epub 2013 Apr 16. PMID: 23588241.
- Simons M, Taft TH, Doerfler B, et al. Narrative review: Risk of eating disorders and nutritional deficiencies with dietary therapies for irritable bowel syndrome. Neurogastroenterol Motil. 2022 Jan;34(1):e14188.
- Staudacher HM, Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut. 2017 Aug;66(8):1517-1527. doi: 10.1136/gutjnl-2017-313750. Epub 2017 Jun 7. PMID: 28592442.
- Szajewska H, Berni Canani R, Domellöf M, Guarino A, Hojsak I, Indrio F et al.; ESPGHAN Special Interest Group on Gut Microbiota and Modifications. Probiotics for the Management of Pediatric Gastrointestinal Disorders: Position Paper of the ESPGHAN Special Interest Group on Gut Microbiota and Modifications. J Pediatr Gastroenterol Nutr. 2023 Feb 1;76(2):232-247. doi: 10.1097/MPG.0000000000003633. Epub 2022 Oct 11. PMID: 36219218.
- Thapar N, Benninga MA, Crowell MD, Di Lorenzo C, Mack I, Nurko S et al. Paediatric functional abdominal pain disorders. Nat Rev Dis Primers. 2020 Nov 5;6(1):89. doi: 10.1038/s41572-020-00222-5. PMID: 33154368.
- van Lanen AS, de Bree A, Greyling A. Efficacy of a low-–FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-ana–lysis. Eur J Nutr. 2021 Sep;60(6):3505-3522. doi: 10.1007/s00394-020-02473-0. Epub 2021 Feb 14. Erratum in: Eur J Nutr. 2021 Jun 28; PMID: 33585949; PMCID: PMC8354978.
- Vasant DH, Paine PA, Black CJ et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut 2021;70:1214-1240 [Guideline].
- Vich Vila A, Imhann F, Collij V et al. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci Transl Med. 2018 Dec 19;10(472):eaap8914.
- Wallace C, Gordon M, Sinopoulou V, Akobeng AK. Probiotics for management of functional abdominal pain disorders in children. Cochrane Database Syst Rev. 2023 Feb 17;2(2):CD012849. doi: 10.1002/14651858.CD012849.pub2. PMID: 36799531; PMCID: PMC9945052.